SNIPR BIOME ApS, a leading CRISPR and microbiome gene therapy biotechnology company, announced dosing of the first human subjects in its phase 1 clinical...
Keymed Biosciences announced that the U.S. Food and Drug Administration (FDA) granted CMG901 Fast Track Designation as monotherapy for the treatment of unresectable or...
BeiGene, Ltd., a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide, announced...
QOL Medical, LLC, a ground-breaking rare disease pharmaceutical company, announced it has selected Optum Frontier Therapies as its new pharmacy partner to support CSID...
WuXi Biologics, a global Contract Research, Development and Manufacturing Organization (CRDMO) service company, announced that the company received the award for Bioprocessing Excellence in...
